A new study found that reported diagnoses of tuberculosis were consistently lower than expected throughout the pandemic, even ...
The firm said that it has received approval for a test that combines the Allsheng-developed Auto-Pure 2400 liquid handling platform with Revvity's T-SPOT.TB test.
Revvity's stock rose after FDA approval of its Auto-Pure 2400 platform integrated with the T-SPOT.TB test, improving latent ...
The NHS has issued a warning over a slow-developing bacterial infection that usually starts with a cough. While the illness ...
Revvity (RVTY) announced that the FDA has approved the Auto-Pure 2400 liquid handling platform with the T-SPOT.TB test. Initially launched ...
Today marks World TB Day 2025 with the WHO calling for more investment into TB treatment and research globally.
Background: Diagnosis and treatment of latent tuberculosis infection (LTBI) is the most effective strategy to control tuberculosis (TB) among patients with HIV infection. The tuberculin skin test ...
A new study published in The Lancet Public Health found that tuberculosis diagnoses plummeted as much as 100 percent in Central and North America in 2021, and nearly 87 percent in Western Europe in ...